Prize - 202109PJT - Taking down the 'undruggable' oncogene: therapeutic implications for novel mechanism-based targeting of MYC

奖 - 202109PJT - 消除“不可成药”的癌基因：基于新型机制的 MYC 靶向治疗的意义

• 批准号: 460118
• 负责人: Sharif Tanveer
• 金额: $ 1.82万
• 依托单位: University of Manitoba
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-09-01 至 2022-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=460118&lang=en
• 关键词: Medulloblastoma; Metabolism; Myc; Oncogenes; Precision-Medicine

In Canada, approximately 1,400 children are diagnosed with cancer each year and approximately 30% of those have a brain tumor. Brain tumors are now the leading cause of cancer-related death in children under the age of 20 and medulloblastoma (MB) is the m

在加拿大，每年约有1，400名儿童被诊断患有癌症，其中约30%患有脑瘤。脑肿瘤现在是20岁以下儿童癌症相关死亡的主要原因，髓母细胞瘤（MB）是最常见的肿瘤。